|
HS Code |
809333 |
| Generic Name | Cefuroxime Sodium |
| Drug Class | Second-generation cephalosporin antibiotic |
| Chemical Formula | C16H15N4NaO8S |
| Molecular Weight | 446.37 g/mol |
| Route Of Administration | Intravenous or intramuscular injection |
| Spectrum Of Activity | Broad-spectrum (both Gram-positive and Gram-negative bacteria) |
| Mechanism Of Action | Inhibits bacterial cell wall synthesis |
| Indications | Respiratory tract infections, urinary tract infections, skin infections, bone and joint infections, septicemia, meningitis |
| Storage Temperature | 2°C to 8°C (refrigerated) |
| Appearance | White to off-white crystalline powder |
| Reconstitution | Reconstituted with sterile water for injection |
| Brand Names | Zinacef, Ceftin |
As an accredited Cefuroxime Sodium factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Cefuroxime Sodium packaging: Sterile, sealed glass vial containing 1 gram powder, labeled with batch number, expiry date, and storage instructions. |
| Shipping | Cefuroxime Sodium should be shipped in tightly sealed containers, protected from light and moisture. It is recommended to transport at 2-8°C (refrigerated) to ensure stability. Proper labeling and documentation are essential, and shipping must comply with regulations for pharmaceutical products. Avoid excessive heat, freezing, or direct sunlight during transit. |
| Storage | Cefuroxime Sodium should be stored in a cool, dry place at a temperature between 2°C and 8°C (36°F to 46°F), protected from light and moisture. The container must remain tightly closed and stored away from incompatible substances. Avoid exposure to excessive heat. Keep out of reach of children and use only within the manufacturer’s recommended shelf life. |
|
Purity 98%: Cefuroxime Sodium with purity 98% is used in intravenous injection preparations, where it ensures consistent antimicrobial efficacy in clinical treatment of severe infections. Particle Size D90<10µm: Cefuroxime Sodium with particle size D90<10µm is used in sterile powder formulations, where it enables rapid dissolution and uniform drug dispersion. Moisture Content ≤1.5%: Cefuroxime Sodium with moisture content ≤1.5% is used in dry powder inhalers, where it provides enhanced stability and prevents degradation during storage. Stability at 25°C: Cefuroxime Sodium stable at 25°C is used in hospital pharmacy compounding, where it maintains effective potency during shelf storage and handling. Assay ≥99%: Cefuroxime Sodium with assay ≥99% is used in pediatric oral suspensions, where it guarantees precise dosing and reliable therapeutic response. Endotoxin Level <0.5EU/mg: Cefuroxime Sodium with endotoxin level <0.5EU/mg is used in parenteral products, where it reduces the risk of pyrogenic reactions in sensitive patients. Melting Point 155–161°C: Cefuroxime Sodium with melting point 155–161°C is used in lyophilized powder manufacturing, where it ensures process compatibility and product integrity. pH (1% solution) 6.0–8.5: Cefuroxime Sodium with pH 6.0–8.5 is used in injectable formulations, where it supports physiological compatibility for patient safety. Heavy Metals ≤0.001%: Cefuroxime Sodium with heavy metals ≤0.001% is used in high-purity pharmaceutical applications, where it minimizes contamination for regulatory compliance. Residual Solvents ≤0.05%: Cefuroxime Sodium containing residual solvents ≤0.05% is used in GMP manufacturing, where it ensures patient safety and meets quality standards. |
Competitive Cefuroxime Sodium prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Doctors and pharmacists rarely sit around debating the best antibiotic on a slow afternoon. Still, patients’ lives change based on what ends up in a syringe or IV bag. Cefuroxime Sodium takes center stage any time infection turns serious and the clock ticks fast. Hospitals recognize it by its clear consistency and sensible dosing: it rarely stirs confusion or panic in those who use it daily. I learned firsthand, from long nights in clinics, that the real value comes from both reliability and the ground-level science backing every vial.
Cefuroxime Sodium belongs to the cephalosporin group. Doctors trust this family for good reason. This drug interrupts bacteria as they build cell walls, making it harder for the infection to dig in. Any time a patient lands in the hospital with pneumonia, urinary tract infections, sinus infections, or blood poisoning, physicians often reach for cefuroxime sodium. It’s not a casual pick—it reflects years of evidence and a push for something that won’t let them down when the margin of error is slim.
Cefuroxime Sodium usually arrives as a white to off-white powder for injection, measured in precise doses, often 750 mg or 1.5 g per vial. These figures reflect hard-won knowledge: too little, and infection lingers; too much, and patients risk side effects. Once the powder touches sterile water, it dissolves fast and pulls no surprises. Nurses get a mixture that draws smoothly into a syringe or an IV drip. In surgery wards, speed matters, and a quick-dissolving powder saves time with every shift change.
Some models arrive with a better ability to tolerate high temperatures during storage, and brands that mix in seconds without clogging needles usually become favorites on the floor. I spent long enough behind a medicine cart to spot the difference. Reliability matters more than a pretty label or a new logo.
Operating rooms demand true workhorses. Cefuroxime Sodium keeps post-surgery infections low, especially after bone or joint operations, heart surgery, or cesarean sections. Surgeons trust it for a reason: over the decades, real-world practice matches the academic literature on infection prevention. In some hospitals, every planned cut involves a dose in the pre-op routine. When a product gets that kind of endorsement—across countries, specialties, and decades—it’s a sign the basics were done right.
Few things turn families inside out as fast as sepsis or serious pneumonia. Cefuroxime Sodium’s spectrum covers most strains responsible for hospital-acquired infections, like Staphylococcus aureus or Escherichia coli. Patients catch infections from catheters, lines, or surgical wounds more often than anyone likes to admit. Fast access to a trusted antibiotic can mean a short hospital stay—and sometimes, life itself.
I’ve seen patients bounce back thanks to timely doses, shaking off fevers and confusion. It’s easy to overlook the value of a steady, familiar medicine until the room goes quiet and the monitors return to their usual rhythm.
The world doesn’t lack choices. First-generation cephalosporins treat plenty of skin and soft tissue infections, but pharmacists and doctors push beyond them when bacteria get trickier. Cefuroxime Sodium, as a second-generation agent, bridges the gap, fighting both Gram-positive and some tough Gram-negative bacteria at once.
Compared to older drugs like cefazolin, cefuroxime steps up against a wider range of organisms, especially those causing infections in the lungs or sinuses. Later generations of cephalosporins, on the other hand, go after even more elusive bugs but sometimes cost more and bring extra side effects.
The gold lies in the balance: Cefuroxime Sodium covers the bugs you’re likely to see, doesn’t destroy the budget, and rarely gives patients much trouble. It’s broad but not reckless, and overusing broader-spectrum agents pushes hospitals down a path to resistance problems nobody wants.
Pharmacists keep it in healthy supply because it rarely triggers allergic reactions in patients who can’t tolerate penicillin. More folks hug this safety line than most realize. For communities with rising resistance or those who overused penicillins in the past, cefuroxime sodium offers a welcome alternative.
In a packed emergency department, speed saves lives, but not at the expense of judgment. Dosing comes down to matching the infection and the patient. Kids, seniors, the critically ill: all need careful attention. Doctors calculate the right amount based on kidney function, age, and the enemy they’re up against.
Cefuroxime sodium does its best work by injection or infusion. By skipping the gut, it floods the body with the right concentration before bacteria can regroup. Once the infection clears or a switch to pills feels safe, therapy continues with oral versions, though those come in a different salt form—cefuroxime axetil.
I’ve watched young and old stir awake after days of confusion, side-stepping ventilators and moving out of intensive care. These moments prove that all the research in the world boils down to lived experience, and cefuroxime sodium’s place on the shelf matters more because of them.
No medicine comes without trade-offs. Nausea, diarrhea, or mild stomach pain show up in some. Rarely, allergic reactions demand swift attention. Folks with severe allergies to penicillin sometimes face crossed wires with cephalosporins. The risks climb with a history of serious reactions, so smart doctors keep backup plans in mind.
Renal function gets special attention, especially in older adults. Dose adjustments keep side effects low and results high. Hospitals often set standard protocols: double-check kidney tests before and during treatment, adjust as needed.
Blood work isn’t just for research. White blood counts and kidney numbers guide therapy, and staff jump in if labs start to drift. After countless ward rounds, it becomes second nature: the right antibiotic, readjusted by the day, brings safer outcomes.
Much of what gets poured into IV lines matters less if bacteria adapt and outsmart us. That’s happened with antibiotics across the board, mostly when prescriptions came too easy or treatments dragged on too long. Cefuroxime Sodium holds its ground today, but prescribers know the risks. Stewardship means using it only as long as necessary and not for every cough.
Resistant organisms challenge every hospital, rich or poor. The miracle drugs of my student years now sometimes stumble against new strains, forcing pivots in treatment. Avoiding unnecessary use, dosing right, and following up with targeted therapy cuts resistance down and keeps cefuroxime sodium useful for the next patient.
A consistent product makes a tangible difference. Some lots mix clear, others cloud or clump. Hospitals remember the batches causing trouble—clogged lines, erratic results, or longer prep times. Those quirks cost hours nobody gets back, especially when every minute matters in care.
The best suppliers stick to the science: proper filtration, uncompromised sterility, and data-driven quality checks. It pays off in fewer complaints and safer patient outcomes. When nurses and pharmacists don’t worry about the next vial, the focus shifts back where it belongs—on the patient, not the product.
In infection control rounds, pharmacy audits, or bedside huddles, the differences between solid and shaky cefuroxime sodium add up. Fewer call-outs for strange side effects, smoother dissolving times, easier training for new staff—all come from strong behind-the-scenes work in manufacturing and supply. Years of hands-on experience teach what no spec sheet covers.
Large health systems wrestle with supply chain snags. Delays in critical antibiotics turn routine care into emergencies. Support for more transparent sourcing—not just the lowest bidder—helps with steady access. Nurses and doctors trust brands that deliver consistent quality, not just familiar names.
Hospitals can build better feedback loops: pharmacists flag poor dissolving or odd reactions, infection teams review outcomes, and procurement responds by pushing for improvements. It takes patience and a willingness to push back if suppliers cut corners. Patients deserve antibiotics that perform as expected, every single time.
In clinics with tighter budgets, prioritizing purchase of reputable, quality-assured cefuroxime sodium pays off with fewer headaches and safer care. Training frontline staff to spot problems early means less waste and more reliability. Hospitals benefit by building relationships with companies that value feedback, adapt their quality control, and never lose sight of patient safety.
On the regulatory side, institutions should push for ongoing audits and clearer reporting. Public documentation of failures and recalls helps buyers make choices rooted in evidence, not just marketing.
Many families never learn the name of the antibiotic that helped them through a sudden illness. What sticks with them is the fast change—fevers drop, breathing eases, recovery begins. From a provider’s side, trust comes from the way patients return to themselves: alert, laughing, and asking when they can go home. Cefuroxime sodium, given in the right dose at the right time, delivers those quiet victories.
After years at the bedside, I measure a drug’s worth not by marketing claims, but by the dozens of small recoveries every month. Cefuroxime sodium belongs among those staples, changing outcomes without fanfare. The science is solid, but the lived experience gives it staying power.
Much research still happens in academic labs and hospital wards. Teams monitor trends in resistance, explore new formulations, and test ideas that shrink side effects or speed up delivery. Faster-acting mixtures, safer excipients, and packaging that keeps costs in check without losing reliability keep cefuroxime sodium relevant.
Health professionals can push for more research funding to update dosing strategies, compare against newcomers, and track resistance changes. Instead of resting on decades-old papers, the field only gains by investing in routine review and transparency.
Education matters too: Physicians new to practice benefit from hands-on mentorship, reviewing cases where cefuroxime sodium wins out, and understanding times it falls short. Patients, when well-informed, play a role by asking questions and sticking with the treatment course through to the end—vital steps in keeping antibiotics useful.
There’s something dependable about drugs that keep earning space on every hospital shelf. Cefuroxime sodium is no exception. Its strengths—predictable coverage, quick dissolving, ease of dosing, and rare complications—set it apart from the crowded field of antibiotics. My own experiences and the stories of thousands of patients reinforce that view.
Medicine moves forward because we remember what works and what doesn’t. Every year brings new choices, but the basics matter most: the right drug, prepared right, used at the right moment. Cefuroxime sodium’s science is solid, but its real value comes through in quiet victories on the ward.
No antibiotic should rest on its old reputation. Companies making cefuroxime sodium owe their users the very best attention to purity, packaging, and delivery. Health workers and patients notice when real effort goes into each batch—less pain, fewer complications, faster recovery.
Regulatory agencies should keep raising the bar. Tracing failures in the field, sharing clear guidance, and demanding better reporting keeps the market honest. Procurement teams, frontline staff, and patients all benefit when standards translate to action—high-quality products, stable supply, and rapid spot checks.
Medical breakthroughs may grab headlines, but steady, reliable antibiotics like cefuroxime sodium do the daily work that makes modern care possible. There’s always room for better formulations, smarter supply chains, and faster training. Lessons from decades of real-world use push the field forward, guiding the next generation of clinicians, patients, and companies.
The fight against infection will always ask for new science, tight teamwork, and practical wisdom. By focusing on what matters most—safe, effective, predictable care—hospitals and clinics everywhere can give patients the kind of recovery stories worth remembering. Cefuroxime sodium stands as a quiet cornerstone for that future, earning trust and delivering results where they’re needed most.